MEDICLIN Aktiengesellschaft (MED.F)
Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
As of 08:02AM CEST. Market open.
Currency in EUR
Valuation measures4
| Market cap (intra-day) | 134.90M |
| Enterprise value | 499.44M |
| Trailing P/E | 5.95 |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 0.18 |
| Price/book (mrq) | 0.67 |
| Enterprise value/revenue | 0.68 |
| Enterprise value/EBITDA | 4.93 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.18 |
| 52-week change 3 | -7.95% |
| S&P500 52-week change 3 | 28.04% |
| 52-week high 3 | 3.0800 |
| 52-week low 3 | 2.2000 |
| 50-day moving average 3 | 2.5356 |
| 200-day moving average 3 | 2.6054 |
Share statistics
| Avg vol (3-month) 3 | 62 |
| Avg vol (10-day) 3 | 3 |
| Shares outstanding 5 | 47.5M |
| Implied shares outstanding 6 | 48.53M |
| Float 8 | 11.44M |
| % held by insiders 1 | 87.73% |
| % held by institutions 1 | 2.95% |
| Shares short 4 | N/A |
| Short ratio 4 | N/A |
| Short % of float 4 | N/A |
| Short % of shares outstanding 4 | N/A |
| Shares short (prior month ) 4 | N/A |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | 30 May 2019 |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Mar 2024 |
Profitability
| Profit margin | -0.77% |
| Operating margin (ttm) | 2.13% |
Management effectiveness
| Return on assets (ttm) | 2.87% |
| Return on equity (ttm) | -2.93% |
Income statement
| Revenue (ttm) | 771.97M |
| Revenue per share (ttm) | 16.25 |
| Quarterly revenue growth (yoy) | 5.70% |
| Gross profit (ttm) | N/A |
| EBITDA | 65.68M |
| Net income avi to common (ttm) | -5.91M |
| Diluted EPS (ttm) | -0.2300 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 118.07M |
| Total cash per share (mrq) | 2.49 |
| Total debt (mrq) | 473.57M |
| Total debt/equity (mrq) | 242.20% |
| Current ratio (mrq) | 1.62 |
| Book value per share (mrq) | 4.11 |
Cash flow statement
| Operating cash flow (ttm) | 77.54M |
| Levered free cash flow (ttm) | 13.37M |
© 2024 Yahoo. All rights reserved.